Loading...
Overall survival and post-progression survival are potent endpoint in phase III trials of second/third-line chemotherapy for advanced or recurrent epithelial ovarian cancer
Purpose: A growing number of treatment options and active compounds in treatments have led to better outcomes for patients with advanced or recurrent epithelial ovarian cancer. We examined the association between progression-free survival (PFS), post-progression survival (PPS) and overall survival (...
Na minha lista:
| Udgivet i: | J Cancer |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Ivyspring International Publisher
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5868151/ https://ncbi.nlm.nih.gov/pubmed/29581765 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.17664 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|